Researchers in the Netherlands presented preliminary results from a multiarm precision medicine trial at the recent ESMO 2017 Congress in Madrid, Spain. The trial, which matches patients with approved drugs based on mutations in their tumor and tissue type, has the potential to uncover treatment options for patients who have exhausted standard therapies, as well as those with rare cancers.

中文翻译：

---

批准的药物可能在更多的癌症中起作用

荷兰的研究人员在最近在西班牙马德里举行的ESMO 2017大会上展示了多臂精准医学试验的初步结果。该试验根据肿瘤和组织类型的突变为患者与获批药物配对，有可能为用尽标准疗法的患者以及罕见癌症的患者提供治疗选择。